Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 23;19:78–84. doi: 10.1016/j.phro.2021.06.001

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 3 — Trade-off between the beam geometries. The target (PTV) is at left ventricular free wall. (A): Target coverage in DVH. (B): dose homogeneity (D₅–D₉₅), overdose (V₁₀₇) and dose coverage (V₉₅). D₅–D₉₅ and V₁₀₇ use the black label on the left y axis and V₉₅ reads the red label on the right y axis). (C): OAR mean doses. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Fig. 3 — Trade-off between the beam geometries. The target (PTV) is at left ventricular free wall. (A): Target coverage in DVH. (B): dose homogeneity (D₅–D₉₅), overdose (V₁₀₇) and dose coverage (V₉₅). D₅–D₉₅ and V₁₀₇ use the black label on the left y axis and V₉₅ reads the red label on the right y axis). (C): OAR mean doses. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)